BGT.AX ASX
Bio-Gene Technology Limited
1W: -5.9%
1M: -11.1%
3M: -5.9%
YTD: -52.9%
1Y: -27.3%
3Y: -82.2%
5Y: -88.6%
A$0.02 ($0.01)
+0.00 (+0.00%)
Weekly Expected Move ±7.9%
A$0
A$0
A$0
A$0
A$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$2M
+23.8% ▲
Capital Expenditures
$2M
+0.0% ▲
5Y CAGR: +264.1%
Free Cash Flow
$0
+100.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$1M
+221.5% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$3M | -$3M | -$2M | -$3M | -$2M |
| Depreciation & Amort. | $44K | $45K | $38K | $42K | $42K |
| Stock-Based Comp. | $453K | $49K | $0 | $0 | $0 |
| Change in Working Capital | $389K | -$281K | -$383K | -$128K | $347K |
| Other Non-Cash Items | $3M | $506K | $0 | $127K | $3K |
| Operating Cash Flow | $44K | -$3M | -$3M | -$3M | -$2M |
| — Investing Activities — | |||||
| Capital Expenditures | -$7K | $0 | -$6K | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$7K | $0 | -$6K | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | -$75K | -$75K | $0 | $51K | -$51K |
| Stock Repurchased | -$236K | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $4M | -$75K | $2M | $1M | $3M |
| Net Change in Cash | $2M | -$3M | -$781K | -$1M | $1M |
| Cash End of Period | $6M | $3M | $2M | $1M | $2M |
| Free Cash Flow | $37K | -$3M | -$3M | -$3M | $0 |